EMBL Researchers Find that the Arrayjet SuperMarathon Inkjet Microarray Can Improve Process. genprowebdirectory ... a series of high-throughput methods were devised at the EMBL Monoclonal ...

For most researchers DNA microarrays are synonymous with high-throughput gene expression analysis. But they also are invaluable genotyping tools. Now that the International HapMap Project (see article ...

January 15, 2006 (Vol. 26, No. 2) Processes Involved in Using DNA Microarray Instrumentation in Protein Microarray Workflow Protein microarrays offer the ability to measure protein expression and ...

In contrast, more comprehensive metagenomics techniques, such as microarrays and high-throughput sequencing, are ideally suited for the task of systematic virus discovery.

High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer. JCO 20 , 2417-2428 (2002). DOI: ...

Discover comprehensive insights into the global biochip market, providing revenue analysis, trends, and forecasts to 2029.

The biomaterials-based high-throughput screening approach that can simultaneously test combinations of physical and biochemical factors for their ability to synergistically form functional joint ...

Tissue microarrays combines tens to hundreds of paraffin-embedded tissue cores into a single paraffin block. It is a practical and highly effective technique for high-throughput analyses of various ...

Potential Next Generation, high-throughput and scalable Axiom microarray technology for Agrigenomics applications. Presented at: APJ Virtual Genetic Solutions Tour 2020 1. Speaker Arjun Kandalam, PhD.

Data Mining Software for Genomics, Proteomics and Expression Data (Part 1) Data Mining Software for Genomics, Proteomics and Expression Data (Part 2) High-throughput (HT) sequencing, microarray ...

PURPOSE: E-cadherin (E-cad) and its associated intracellular molecules, catenins, are critical for intercellular epithelial adhesion and are often expressed in non–small-cell lung carcinomas (NSCLCs).